Drugs / PoPex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05915117 | Apr → Dec 2023 | metabolic syndrome X | University of Banja Luka | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PoPex | “PoPex in form of capsule will be orally administered in total daily dose of 500/mg in subjects with metabolic syndrome and obesity over 8 weeks.” NCT05915117 ↗ |
| Known as | Polyphenols of pomegranate fruit peel extract | “Polyphenols of pomegranate fruit peel extract (PoPex)” NCT05915117 ↗ |
| Route | Oral | “orally administered” NCT05915117 ↗ |